Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
Josè Antonio Pérez-Simón(Instituto de Biomedicina de Sevilla), Jesús F. San Miguel(Clinica Universidad de Navarra), Lourdes Vázquez, María Díez‐Campelo(Complejo Hospitalario de Salamanca), Albert Altés(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Jordi Sierra(Hospital de Sant Pau), Consuelo del Cañizo(Instituto de Investigación Biomédica de Salamanca), Salut Brunet(Institut Català d'Oncologia), Dolores Caballero(Complejo Hospitalario de Salamanca), Rodrigo Martino(Universitat Autònoma de Barcelona)
Cited by 117
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k